These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 25708274

  • 1. Role of 5-HT2 receptors in diabetes: Swertiamarin seco-iridoid glycoside might be a possible 5-HT2 receptor modulator.
    Sonawane RD, Deore VB, Patil SD, Patil CR, Surana SJ, Goyal RK.
    Physiol Behav; 2015 May 15; 144():66-72. PubMed ID: 25708274
    [Abstract] [Full Text] [Related]

  • 2. The Molecular Targets of Swertiamarin and its Derivatives Confer Anti- Diabetic and Anti-Hyperlipidemic Effects.
    Patel N, Tyagi RK, Tandel N, Garg NK, Soni N.
    Curr Drug Targets; 2018 May 15; 19(16):1958-1967. PubMed ID: 29623834
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of swertiamarin on dyslipidaemia in streptozotocin-induced type 2 diabetic rats.
    Vaidya H, Prajapati A, Rajani M, Sudarsanam V, Padh H, Goyal RK.
    Phytother Res; 2012 Aug 15; 26(8):1259-61. PubMed ID: 22228612
    [Abstract] [Full Text] [Related]

  • 4. RP-HPLC analysis of seco-iridoid glycoside swertiamarin from different Swertia species.
    Kshirsagar PR, Pai SR, Nimbalkar MS, Gaikwad NB.
    Nat Prod Res; 2016 Aug 15; 30(7):865-8. PubMed ID: 26299409
    [Abstract] [Full Text] [Related]

  • 5. A systematic review of the protective role of swertiamarin in cardiac and metabolic diseases.
    Leong XY, Thanikachalam PV, Pandey M, Ramamurthy S.
    Biomed Pharmacother; 2016 Dec 15; 84():1051-1060. PubMed ID: 27780133
    [Abstract] [Full Text] [Related]

  • 6. Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin - A Promising Natural Lead for New Drug Discovery and Development.
    Muhamad Fadzil NS, Sekar M, Gan SH, Bonam SR, Wu YS, Vaijanathappa J, Ravi S, Lum PT, Dhadde SB.
    Drug Des Devel Ther; 2021 Dec 15; 15():2721-2746. PubMed ID: 34188450
    [Abstract] [Full Text] [Related]

  • 7. 5-HT2 ligands in the treatment of anxiety and depression.
    Quesseveur G, Nguyen HT, Gardier AM, Guiard BP.
    Expert Opin Investig Drugs; 2012 Nov 15; 21(11):1701-25. PubMed ID: 22917059
    [Abstract] [Full Text] [Related]

  • 8. Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies.
    Millan MJ.
    Therapie; 2005 Nov 15; 60(5):441-60. PubMed ID: 16433010
    [Abstract] [Full Text] [Related]

  • 9. Swertiamarin decreases lipid accumulation dependent on 3-ketoacyl-coA thiolase.
    Wang J, He J.
    Biomed Pharmacother; 2019 Apr 15; 112():108668. PubMed ID: 30784937
    [Abstract] [Full Text] [Related]

  • 10. Mutagenesis analysis of the serotonin 5-HT2C receptor and a Caenorhabditis elegans 5-HT2 homologue: conserved residues of helix 4 and helix 7 contribute to agonist-dependent activation of 5-HT2 receptors.
    Xie J, Dernovici S, Ribeiro P.
    J Neurochem; 2005 Jan 15; 92(2):375-87. PubMed ID: 15663485
    [Abstract] [Full Text] [Related]

  • 11. Evidence for the involvement of the serotonergic 5-HT2A/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice.
    Jesse CR, Wilhelm EA, Bortolatto CF, Nogueira CW.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar 17; 34(2):294-302. PubMed ID: 19961893
    [Abstract] [Full Text] [Related]

  • 12. [Effects of 5-HT1 and 5-HT2 serotonin receptors on anxiety- and depression-like behavior in female rats].
    Fedotova IuO.
    Eksp Klin Farmakol; 2011 Mar 17; 74(3):6-9. PubMed ID: 21598629
    [Abstract] [Full Text] [Related]

  • 13. A new HPTLC densitometric method for analysis of swertiamarin in Enicostemma littorale and commercial formulations.
    Alam P, Ali M, Singh R, Shakeel F.
    Nat Prod Res; 2011 Jan 17; 25(1):17-25. PubMed ID: 21240756
    [Abstract] [Full Text] [Related]

  • 14. Determination of novel nitrogen-containing metabolite after oral administration of swertiamarin to rats.
    Wang ZG, Wang XJ, Sun H, Chen L, Ma CM.
    J Asian Nat Prod Res; 2012 Jan 17; 14(2):176-81. PubMed ID: 22296159
    [Abstract] [Full Text] [Related]

  • 15. Effects of Swertia japonica extract and its main compound swertiamarin on gastric emptying and gastrointestinal motility in mice.
    Kimura Y, Sumiyoshi M.
    Fitoterapia; 2011 Sep 17; 82(6):827-33. PubMed ID: 21571047
    [Abstract] [Full Text] [Related]

  • 16. Sweritranslactone D, a hepatoprotective novel secoiridoid dimer with tetracyclic lactone skeleton from heat-transformed swertiamarin.
    Zou YD, Ma XX, Du SN, Qi PX, He FY, Yang ZY, Tan WH, Khan A, Zhou ZH, Liu L.
    Fitoterapia; 2021 Jun 17; 151():104879. PubMed ID: 33689876
    [Abstract] [Full Text] [Related]

  • 17. [Antidepressant psychopharmacotherapy].
    Retamal P.
    Rev Med Chil; 2001 Jul 17; 129(7):813-8. PubMed ID: 11552452
    [Abstract] [Full Text] [Related]

  • 18. A model to explain the therapeutic effects of serotonin reuptake inhibitors: the role of 5-HT2 receptors.
    Landén M, Thase ME.
    Psychopharmacol Bull; 2006 Jul 17; 39(1):147-66. PubMed ID: 17065978
    [Abstract] [Full Text] [Related]

  • 19. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors.
    Wang R, Xu Y, Wu HL, Li YB, Li YH, Guo JB, Li XJ.
    Eur J Pharmacol; 2008 Jan 06; 578(1):43-50. PubMed ID: 17942093
    [Abstract] [Full Text] [Related]

  • 20. Involvement of 5-HT2 receptors in the expression of withdrawal diarrhea in morphine-dependent mice.
    Mori T, Komiya S, Ohya J, Uzawa N, Sugiyama K, Saitoh Y, Shibasaki M, Suzuki T.
    Eur J Pharmacol; 2014 Oct 05; 740():160-7. PubMed ID: 25034809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.